Cancer-Fighting cell therapy tested for tough lupus cases
NCT ID NCT06310811
Summary
This early-stage study is testing a new therapy called RD06-04, which uses a patient's own modified immune cells (CAR-T cells), for people with moderate to severe lupus. The main goals are to check if the treatment is safe, see how the body processes it, and find the best dose. Up to 12 participants will receive one of two dose levels to help researchers understand the risks and potential benefits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wuhan Union
Wuhan, Hubei, 430000, China
Conditions
Explore the condition pages connected to this study.